Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history shows a minor UI text change in the contact information label (capitalization) and a revision tag update from v3.6.6 to v3.7.0.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new site revision entry, v3.6.6, is added to the study record history, replacing the prior v3.6.5 and indicating a recent system update.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision bumped from v3.6.4 to v3.6.5 in the page history, signaling an internal software update to the record history interface.SummaryDifference0.1%

- Check65 days agoChange DetectedThe Record History now shows the platform revision updated to v3.6.4, replacing v3.6.3. This is a system update to the ClinicalTrials.gov interface and does not change the study data or its presentation beyond the version label.SummaryDifference0.1%

- Check86 days agoChange DetectedThe study record history now shows a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry, reflecting an updated release in the history log.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study record history now shows a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed, updating the version history.SummaryDifference0.1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.